Researchers have found that the combination of some rheumatic diseases (such as rheumatoid arthritis, psoriatic arthritis, axial spondylarthritis, and systemic lupus erythematosus) and being over 65 can significantly increase the...
Most research into the risk of severe COVID-19 focuses on age and underlying medical conditions, while studies about how lifestyle can affect severity are just emerging....
For a long time during the COVID-19 pandemic, the novel coronavirus was associated primarily with lung damage. However, emerging research suggests an array of other conditions survivors of a severe form COVID-19 need to cope with....
Although about 80 per cent of people with symptoms of Covid-19 experience only a mild form of the disease, those patients who have spent time in intensive care units (ICU) often have long months of rehabilitation ahead of them....
Scientists are proposing to use biomarkers – molecules occurring in the blood – to inform doctors about the likely disease progress of COVID-19 patients....
There is growing evidence that COVID-19 is causing brain damage in patients and that the SARS-CoV-2 virus behind the disease may itself attack the central nervous system....
There are at least half a dozen COVID-19 vaccine candidates in development and testing. These include whole virus vaccines, recombinant subunit vaccines and next-generation nucleic acid vaccines....
‘Convalescent plasma therapy’ (CPT) – using the antibody-containing blood components of recovered COVID-19 patients – could be an effective treatment for people critically sick with the disease....
Currently, we don’t have clear evidence to suggest that the virus is weakening despite a recent claim from a leading Italian virologist that SARS-CoV-2 was "losing its potency". This comment has drawn criticism from the...